معرفی
Cecilia Linde is a Professor at the Department of Medicine, Solna, Karolinska Institutet. She holds a Docent degree from Karolinska Institutet (1997) and has been a faculty member since at least 2020, advancing to Senior Professor in 2025. Her research focuses on cardiovascular disease, particularly heart failure, cardiac resynchronization therapy (CRT), and clinical management of arrhythmias like atrial fibrillation. She is affiliated with the Endothelial dysfunction in atherosclerotic cardiovascular disease research group led by John Pernow.
Education:
- Docent, Karolinska Institutet, 1997
Research Interests:
- Cardiac devices (CRT, pacemakers)
- Heart failure mechanisms and therapy
- Atrial fibrillation management
- Clinical trial design
- Cardiovascular biomarkers
Publications Trends: Her work emphasizes translational cardiology, with recent focus on CRT efficacy across patient subgroups, device-guided AF management, and machine learning applications in predicting CRT outcomes. She collaborates globally on large-scale trials like REVERSE and NOAH-AFNET 6.
Awards: No specific prizes mentioned, though her extensive editorial contributions to top journals like European Heart Journal and Circulation reflect peer recognition.
Advising & Grants: While no grant details are provided, her involvement in multi-center clinical trials indicates significant research funding. She has not listed formal advisees but co-authors numerous international collaborators.
Labs/Teams: Active in the John Pernow research group studying endothelial dysfunction and atherosclerosis. Collaborates with institutions globally on cardiovascular device trials and guideline development.
